- Home
- PRKS vs SRPT Comparison
PRKS vs SRPT Comparison
Compare PRKS & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRKS | SRPT |
|---|---|---|
| Founded | 1959 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 2013 | 1997 |
Fundamental Metrics
Financial Performance| Metric | PRKS | SRPT |
|---|---|---|
| Price | $34.68 | $21.01 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 29 |
| Target Price | ★ $50.82 | $26.23 |
| AVG Volume (30 Days) | 977.5K | ★ 3.3M |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.27 | N/A |
| Revenue | $1,673,396,000.00 | ★ $2,413,715,000.00 |
| Revenue This Year | N/A | $13.83 |
| Revenue Next Year | $2.18 | N/A |
| P/E Ratio | $10.61 | ★ N/A |
| Revenue Growth | N/A | ★ 47.15 |
| 52 Week Low | $29.62 | $10.42 |
| 52 Week High | $60.63 | $129.84 |
Technical Indicators
Market Signals| Indicator | PRKS | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 40.11 | 52.00 |
| Support Level | $34.82 | $20.14 |
| Resistance Level | $36.06 | $22.97 |
| Average True Range (ATR) | 1.17 | 1.29 |
| MACD | 0.35 | -0.06 |
| Stochastic Oscillator | 13.88 | 50.96 |
Price Performance
Historical ComparisonAbout PRKS United Parks & Resorts Inc.
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.